A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy

被引：1
|
作者：
Villanueva, C. [1 ]
Awada, A. [2 ]
Campone, M. [3 ]
Machiels, J. P. [4 ]
Besse, T. [2 ]
Magherini, E. [5 ]
Dubin, F. [5 ]
Semiond, D. [5 ]
Pivot, X. [1 ]
机构：
[1] Hop Jean Minjoz, F-25030 Besancon, France
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
[3] Ctr Rene Gauducheau, F-44035 Nantes, France
[4] Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium
[5] Sanofi Aventis, Paris, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70917-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [31] Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer
    Susnjar, S.
    Bosnjak, S.
    Radulovic, S.
    Stevanovic, J.
    Gajic-Dobrosavljevic, M.
    Kreacic, M.
    JOURNAL OF BUON, 2007, 12 (02): : 189 - 196
  • [32] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer
    Schilsky, RL
    Bertucci, D
    Vogelzang, NJ
    Kindler, HL
    Ratain, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 582 - 587
  • [34] Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab after Anthracycline, Taxane, and Capecitabine
    Tanabe, Masahiko
    CASE REPORTS IN ONCOLOGY, 2016, 9 (02): : 422 - 426
  • [35] PHASE 3 STUDY OF NKTR-102 VERSUS TREATMENT OF PHYSICIAN'S CHOICE (TPC) IN PATIENTS (PTS) WITH LOCALLY RECURRENT OR METASTATIC BREAST CANCER (MBC) PREVIOUSLY TREATED WITH AN ANTHRACYCLINE, A TAXANE, AND CAPECITABINE (ATC)
    Cortes, J.
    Perez, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 43 - 44
  • [36] Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer
    Keun Seok Lee
    In Hae Park
    Byung-Ho Nam
    Jungsil Ro
    Investigational New Drugs, 2013, 31 : 152 - 159
  • [37] Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer
    Lee, Keun Seok
    Park, In Hae
    Nam, Byung-Ho
    Ro, Jungsil
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 152 - 159
  • [38] Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study
    Malmstrom, Annika
    Hansen, Jorgen
    Malmberg, Lena
    Carlsson, Lena
    Svensson, Jan-Henry
    Ahlgren, Johan
    Ahlin, Cecila
    Jansson, Tomas
    Westberg, Ronny
    ACTA ONCOLOGICA, 2010, 49 (01) : 35 - 41
  • [39] Phase II study of the combination of docetaxel, capecitabine and carboplatinum as first line therapy in metastatic breast cancer (MBC)
    Mokaddem, Walid
    Kattan, Joseph
    Chahine, Georges
    Nasr, Fadi
    Farhat, Fadi
    Tueni, Elias
    Dagher, Joya
    Younes, Fariha
    Ghosen, Marwan
    ANNALS OF ONCOLOGY, 2004, 15 : 45 - 46
  • [40] Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane
    Verma, Sunil
    Wong, Nan Soon
    Trudeau, Maureen
    Joy, Anil
    Mackey, John
    Dranitsaris, George
    Clemons, Mark
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 297 - 302
12345